Profil
David G.
Halverson currently works at Haematologic Technologies LLC, as President & Chief Executive Officer from 2023.
Mr. Halverson also formerly worked at Army Emergency Relief, as Director, Protea Biosciences Group, Inc., as President & Chief Business Officer, and Scorpius BioManufacturing, Inc., as President.
Postes actifs de David G. Halverson
| Sociétés | Poste | Début |
|---|---|---|
Haematologic Technologies LLC
Haematologic Technologies LLC Medical SpecialtiesHealth Technology Manufactures plasma proteins which are intended for in vitro research use | Directeur Général | 01/04/2023 |
Anciens postes connus de David G. Halverson
| Sociétés | Poste | Fin |
|---|---|---|
| PROTEA BIOSCIENCES GROUP, INC | President | 01/12/2017 |
Scorpius BioManufacturing, Inc.
Scorpius BioManufacturing, Inc. BiotechnologyHealth Technology Operates as a contract research, development and manufacturing company that focuses on cell & gene-based therapies and molecule biologics | President | - |
Army Emergency Relief
Army Emergency Relief Services to the Health IndustryHealth Services Provides emergency financial assistance to army | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Army Emergency Relief
Army Emergency Relief Services to the Health IndustryHealth Services Provides emergency financial assistance to army | Health Services |
Protea Biosciences Group, Inc.
Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides innovative bioanalytical solutions | Commercial Services |
Haematologic Technologies LLC
Haematologic Technologies LLC Medical SpecialtiesHealth Technology Manufactures plasma proteins which are intended for in vitro research use | Health Technology |
Scorpius BioManufacturing, Inc.
Scorpius BioManufacturing, Inc. BiotechnologyHealth Technology Operates as a contract research, development and manufacturing company that focuses on cell & gene-based therapies and molecule biologics | Health Technology |
















